Tag: lungcancer
Afatinib Outperforms Gefitinib in Advanced Non-Small Cell Lung Cancer
By Erik J. MacLaren, PhD
The pan-ErbB inhibitor afatinib (Gilotrif) improves progression-free survival (PFS), time-to-treatment-failure (TTF) rate, and objective response rate (ORR) compared to the...
